Self-care with overactive bladder involves making lifestyle changes, taking medications, going to physical therapy, and ...

Researchers found that the immunotherapy drug pembrolizumab significantly extends the cancer-free period for patients with ...

A new study in mice by researchers at the Herbert Irving Comprehensive Cancer Center (HICCC) has identified a promising drug ...

This is the first instance of an immunotherapy drug significantly improving overall survival in patients with this type of ...

Results from a large clinical trial show that treatment with an immunotherapy drug may nearly double the length of time people with high-risk, muscle-invasive bladder cancer are cancer-free following ...

AstraZeneca has revealed the data for Imfinzi in muscle-invasive bladder cancer (MIBC) that it hopes will be enough to secure ...

A new study in mice by researchers at the Herbert Irving Comprehensive Cancer Center (HICCC) has identified a promising drug ...

BARCELONA — Adding the immune checkpoint inhibitor durvalumab to standard treatment for muscle-invasive bladder cancer (MIBC) ...

Cathy Lee Mendelsohn, PhD A new study in mice by researchers at the Herbert Irving Comprehensive Cancer Center (HICCC) has ...

Adding perioperative durvalumab (Imfinzi) to neoadjuvant chemotherapy significantly improved survival outcomes in ...

In patients with muscle-invasive bladder cancer, Imfinzi reduced the risk of disease recurring by 32% when given alongside ...